Learn more

KABIGEN AB

Overview
  • Total Patents
    89
About

KABIGEN AB has a total of 89 patent applications. Its first patent ever was published in 1980. It filed its patents most often in Sweden, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are JCR PHARMACEUTICALS CO LTD, STEIDLER LOTHAR and DIACCURATE.

Patent filings per year

Chart showing KABIGEN ABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Uhlen Mathias 14
#2 Moks Tomas 11
#3 Mutt Viktor 9
#4 Nilsson Bjoern 9
#5 Joernvall Hans 8
#6 Pohl Gunnar 8
#7 Abrahmsen Lars 7
#8 Lowenadler Bjorn 7
#9 Curstedt Tore 6
#10 Robertsson Bengt 6

Latest patents

Publication Filing date Title
WO9107497A1 Expression of heterologous proteins using eucaryotic cells
US5096886A Antibacterial polypeptides
US5202121A Thrombolytic compositions
EP0366638A2 Neuromodulatory peptide
EP0356409A2 A method for the production and isolation of a fusion protein in eukaryotic cells
EP0346316A2 Fusion protein and its use
WO8900167A1 Proteins and protein compositions and their use
EP0297066A1 Novel fibrinolytic enzymes
EP0297068A2 Mammal intestine hormone precursor
EP0243333A2 Preparation of fused proteins, antibodies and processes therefore
EP0225860A2 A method to export gene products to the growth medium of Gram negative bacteria
EP0230869A2 Construction of an IgG binding protein to facilitate downstream processing using protein engineering
EP0227619A2 New protein and its use
AU6521186A Lytic viruses as expression vectors, host cell containing same and process for protein production
EP0254717A1 Human intestinal hormone and its use
WO8605495A1 Mammal intestinal hormone precursor and its use
EP0130166A1 A recombinant plasmid, a transformant microorganism, a polydeoxy-ribonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
US4520016A Bacteriolytic proteins
US4355104A Bacteriolytic proteins